MoneyWorks4Me

Indoco Remedies informs about press release

03 May 2023 Evaluate

Further to the intimation dated January 23, 2023, on the audit conducted by the United States Food and Drug Administration (USFDA) at its Solid Oral Formulation Facility (Plant 1) at Goa, from January 16, 2023 to January 20, 2023, Indoco Remedies has informed that the Company has received the Establishment Inspection Report (EIR) indicating closure of the inspection. It has enclosed press release in this regard.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..